HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

Week Ending: June 26, 2010

This Issue:

90% Of HCV Patients to Be Treated with Triple Therapy Regimens, Finds Decision Resources Hepatitis B Screening Serves 180 Benitec Limited (ASX:BLT) Granted Hepatitis C RNA Interference Patent in US North County Hospital Patients Potentially Exposed to Viruses Honda: It’s Time to Get Serious about Viral Hepatitis Transplanted Organs Are Often Far from Perfect Family Man Leigh Fought Illness with a Smile on His Face Thought Rare, Virus Strikes Twice in S.A. ASCO: No Evidence to Support Routine Hepatitis B Virus Screening before Chemotherapy Caritas Worries Tension May Derail Korea Aid New Study Confirms Link between Nonalcoholic Steatohepatitis, Liver Cancer Grant Awarded to Fight Hepatitis C Push for Needle Exchange in Jail Kingston Hospital's Family Birth Place is Honored Study Busts Liver Disease Myth Rocker Gregg Allman Has Liver Transplant Physicians Test for Hepatitis C Based on Risk Factors but Should Expand Screening for High-Prevalence Age Group OraSure Technologies Receives FDA Approval for OraQuick® HCV Rapid Test, the First Rapid HCV Test Approved for Sale in the U.S. Screening Cancer Patients for Hepatitis B: Should it Be Routine? Silencing Hepatitis B Virus Prevent Recurrence of Liver Cancer

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-367.html